Flagship Ventures is a venture capital firm focused on creating, financing and building innovative companies. Founded in 2000, Flagship manages over $600 million in early-stage funds and operates from its offices at Kendall Square in Cambridge, MA. With an active portfolio of over 40 companies, the firms strategy is to balance its investments across three principal business sectors: Therapeutics, Life Science Tools & Diagnostics, and BioEnergy/Cleantech.
The Flagship investment team consists of 10 professionals and is led by co-founders Noubar Afeyan and Ed Kania. Complementing the internal team is an extensive network of academic...
More >>
Flagship Ventures is a venture capital firm focused on creating, financing and building innovative companies. Founded in 2000, Flagship manages over $600 million in early-stage funds and operates from its offices at Kendall Square in Cambridge, MA. With an active portfolio of over 40 companies, the firms strategy is to balance its investments across three principal business sectors: Therapeutics, Life Science Tools & Diagnostics, and BioEnergy/Cleantech.
The Flagship investment team consists of 10 professionals and is led by co-founders Noubar Afeyan and Ed Kania. Complementing the internal team is an extensive network of academic and industrial advisors who are actively engaged in evaluating and helping develop new ventures. During the past two decades Flagship's principals have been involved as founders or investors in many highly successful ventures including: Adnexus Therapeutics, Alere Medical, Aspect Medical, Celera Genomics, ChemGenics Pharmaceuticals, Color Kinetics, Cytyc, DataSage, Exact Sciences, Helicos Biosciences, Hypnion, IDEXX, Morphotek, PerSeptive Biosystems and TripAdvisor.
<< Less
LS9, Inc., the Renewable Petroleum Company(TM), is a privately-held industrial biotechnology company pursuing the commercial development of renewable fuels and chemicals. LS9 is applying synthetic biology to produce proprietary biofuels that are compatible with existing fuel distribution and consumer infrastructure, as well as high-value industrial chemicals. LS9 is t...
More >>
LS9, Inc., the Renewable Petroleum Company(TM), is a privately-held industrial biotechnology company pursuing the commercial development of renewable fuels and chemicals. LS9 is applying synthetic biology to produce proprietary biofuels that are compatible with existing fuel distribution and consumer infrastructure, as well as high-value industrial chemicals. LS9 is the pioneer in the commercial development of fermentation derived hydrocarbon biofuels and its patent-pending Renewable Petroleum(TM) products are custom engineered in the lab to address immediate market needs for clean energy alternatives to petroleum. The company was founded in 2005 and venture capital firms Flagship Ventures, Khosla Ventures, and Lightspeed Venture Partners have provided funding to date. LS9 is headquartered in South San Francisco, California. For more information about LS9 products and capabilities, please visit www.ls9.com.
<< Less
Pervasis Therapeutics, Inc. is developing biologically active therapeutics to regulate vascular repair and restore blood flow to critical organs and vasculature. The company's flagship product, Vascugel, is a cell-based therapeutic matrix developed to reestablish healthy vasculature after vascular injury. Per the company, Vascugel has the capability to be delivered ...
More >>
Pervasis Therapeutics, Inc. is developing biologically active therapeutics to regulate vascular repair and restore blood flow to critical organs and vasculature. The company's flagship product, Vascugel, is a cell-based therapeutic matrix developed to reestablish healthy vasculature after vascular injury. Per the company, Vascugel has the capability to be delivered in both open surgical and minimally invasive procedures. Pervasis is also exploring broader indications in non-vascular applications.
<< Less
Eleven Biotherapeutics is a biopharmaceutical company focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics.
AVEO Pharmaceuticals has built inducible, tissue-specific in vivo cancer models with which to discover drugs. Each model contains signature genetic mutations, and natural genetic variation akin to the genetic heterogeneity encountered across different primary tumors. Further, tumors that arise in this model have a number of differing phenotypes, including significant ...
More >>
AVEO Pharmaceuticals has built inducible, tissue-specific in vivo cancer models with which to discover drugs. Each model contains signature genetic mutations, and natural genetic variation akin to the genetic heterogeneity encountered across different primary tumors. Further, tumors that arise in this model have a number of differing phenotypes, including significant variation in tissue architecture and angiogenic potential.
<< Less
Quanterix Corporation is developing a platform for single molecule analysis that aims to bring an unprecedented level of sensitivity, precision, and assay robustness to clinical diagnostics, drug development, and life science research. Per the company, their unique approach permits rapid quantification and analysis of individual proteins and small molecules within ...
More >>
Quanterix Corporation is developing a platform for single molecule analysis that aims to bring an unprecedented level of sensitivity, precision, and assay robustness to clinical diagnostics, drug development, and life science research. Per the company, their unique approach permits rapid quantification and analysis of individual proteins and small molecules within complex biological samples, enabling us to address a variety of unmet medical needs. The focus of Quanterix is to provide physicians, drug developers, and researchers with the ability to detect and analyze important biomolecules within complex biological samples at the level of single molecules. Quanterix has utilized the ability to detect single molecules to quantify the concentration of proteins in human serum at levels that are more than a thousand fold lower than the gold standard ELISA assay. Quanterix Corporation is a privately held company based in Cambridge, Massachusetts.
<< Less
Oasys (Osmotic Application Systems) is a Cambridge MA based company developing a suite of water treatment products to address the growing, global water crisis. The Company's Engineered Osmosis (EOTM) process provides a treatment system that per the company, can produce clean, potable water at significantly lower cost than current desalination methods.
CombinatoRx, Incorporated is a biopharmaceutical company focused on developing new medicines built from synergistic combinations of approved drugs, designed to attack disease on multiple fronts. CombinatoRx applies its proprietary combination drug discovery technology to identify new combination product candidates in a number of disease areas, including immunoinflamma...
More >>
CombinatoRx, Incorporated is a biopharmaceutical company focused on developing new medicines built from synergistic combinations of approved drugs, designed to attack disease on multiple fronts. CombinatoRx applies its proprietary combination drug discovery technology to identify new combination product candidates in a number of disease areas, including immunoinflammatory disease, oncology, metabolic disease, neurodegenerative disease, and infectious disease.
<< Less
Tira Wireless is a full-service publisher of a portfolio of trusted Wireless Java applications supporting the diverse needs of today's mobile subscribers. Tira Wireless offers mobile operators and developers a "full-service" publishing model that aims to ensure the delivery of trusted wireless java applications to mobile subscribers through Tira's stringent certifica...
More >>
Tira Wireless is a full-service publisher of a portfolio of trusted Wireless Java applications supporting the diverse needs of today's mobile subscribers. Tira Wireless offers mobile operators and developers a "full-service" publishing model that aims to ensure the delivery of trusted wireless java applications to mobile subscribers through Tira's stringent certification to standards for security, usability, and robustness.
<< Less
This page is accessible to a membership level higher than you. To improve your membership level you can try the following:
Review More Companies
Complete your profile
Improve your fanbase
Add/Edit more companies
Send a request to site admin at membership@chubbybrain.com requesting to upgrade your membership level. If your profile is eligible, your membership level will be upgraded and you will be notified.
Why can I not access this page?
This page is accessible to a membership level higher than you. To improve your membership level you can try the following:
Review More Companies
Complete your profile
Improve your fanbase
Add/Edit more companies
Send a request to site admin at membership@chubbybrain.com requesting to upgrade your membership level. If your profile is eligible, your membership level will be upgraded and you will be notified.
9,817 Investors 
